Immatics NV (IMTX)

Immatics NV (IMTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1B; returns 1 day -3.1%, 1 week +8.6%, 1 year -28.2%.

Immatics NV is a clinical-stage biopharmaceutical company specializing in the development of T-cell-redirecting immunotherapies for cancer patients. As a pre-commercial entity, its revenue is primarily generated through strategic collaboration and partnership agreements with larger pharmaceutical companies, not product sales.

Groups IMTX belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Immunotherapy
• Biopharmaceutical
• Cancer Therapeutics
• Life Sciences
• Healthcare
• Bispecific Antibodies
• Precision Medicine
• Autologous Cell Therapy
• Biologics
• Clinical Stage

IMTX financial model: income statement, cash flow and balance sheet